News
Much of the public distrust stems from false information around messenger RNA (mRNA) vaccines for COVID-19, even though they ...
While Moderna isn’t looking to replace classical computing with quantum entirely, the company is interested in building a “quantum-enabled biotechnology pipeline.” In conjunction with IBM, the ...
StockStory.org on MSN1d
Reflecting On Therapeutics Stocks’ Q1 Earnings: Moderna (NASDAQ:MRNA)As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...
The deal, announced on June 30, will advance a subsect of research into new autoimmune treatments that began at Penn.
How does a cell know when it’s been damaged? A molecular alarm, set off by mutated RNA and colliding ribosomes, signals ...
Because they rely on hosts for a majority of functions, viruses aren’t considered alive. But entities like this one ...
Study reveals how cells regulate repair protein production to prevent DNA damage over-repair or under-repair, aiding cell ...
The elephant vaccine closely resembles other mRNA vaccines made for humans. mRNA packed in lipid nanoparticles carries ...
3d
Barchart on MSNWhat to Expect From Moderna's Next Quarterly Earnings ReportModerna is expected to announce its second-quarter results in the upcoming month, and analysts expect a slight reduction in ...
Professor Hirohide Saito and his research team have developed a new microRNA-responsive hybrid mRNA switch, enabling precise, ...
Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases. Promising results, but Phase ...
In the vast and often unseen world of microscopic life, a recent discovery may force scientists to rethink what it means to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results